[Schizophrenia and treatment with lithium salts. Current data from the literature].
The use of lithium salts in the treatment of schizophrenia remains as contested as the concept of schizo-affective disorders. Many studies have attempted to define the interest and the risks of lithiotherapy beside the major effective disorders. Only a few of them can be credited with a strict methodology. The authors have only taken into account the comparative double-blind studies, namely between lithium and neuroleptics. Some predictive criteria of the therapeutic effect seem to emerge: the notion of a sudden outbreak, a good premorbid adjustment, appear more significant than the presence or absence of effective symptoms during the psychotic episode.
D001714:Bipolar Disorder / Q000188:drug therapy; D004311:Double-Blind Method; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D011379:Prognosis; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012917:Social Adjustment
D008094:Lithium
Schizophrénies et traitement par les sels de lithium. Données actuelles de la littérature.